- Home
- PRPH vs BIAF Comparison
PRPH vs BIAF Comparison
Compare PRPH & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- BIAF
- Stock Information
- Founded
- PRPH 1989
- BIAF 2014
- Country
- PRPH United States
- BIAF United States
- Employees
- PRPH N/A
- BIAF N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PRPH Health Care
- BIAF Health Care
- Exchange
- PRPH Nasdaq
- BIAF Nasdaq
- Market Cap
- PRPH 10.7M
- BIAF 12.2M
- IPO Year
- PRPH 1997
- BIAF 2022
- Fundamental
- Price
- PRPH $0.39
- BIAF $0.89
- Analyst Decision
- PRPH
- BIAF Hold
- Analyst Count
- PRPH 0
- BIAF 1
- Target Price
- PRPH N/A
- BIAF N/A
- AVG Volume (30 Days)
- PRPH 1.7M
- BIAF 28.2M
- Earning Date
- PRPH 03-31-2025
- BIAF 05-14-2025
- Dividend Yield
- PRPH N/A
- BIAF N/A
- EPS Growth
- PRPH N/A
- BIAF N/A
- EPS
- PRPH N/A
- BIAF N/A
- Revenue
- PRPH $6,770,000.00
- BIAF $9,362,022.00
- Revenue This Year
- PRPH N/A
- BIAF $25.19
- Revenue Next Year
- PRPH $64.06
- BIAF $20.00
- P/E Ratio
- PRPH N/A
- BIAF N/A
- Revenue Growth
- PRPH N/A
- BIAF 269.68
- 52 Week Low
- PRPH $0.22
- BIAF $0.24
- 52 Week High
- PRPH $7.48
- BIAF $3.16
- Technical
- Relative Strength Index (RSI)
- PRPH 45.88
- BIAF 67.83
- Support Level
- PRPH $0.35
- BIAF $0.24
- Resistance Level
- PRPH $0.60
- BIAF $1.55
- Average True Range (ATR)
- PRPH 0.08
- BIAF 0.12
- MACD
- PRPH 0.00
- BIAF 0.08
- Stochastic Oscillator
- PRPH 27.59
- BIAF 49.58
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.